Pacer Advisors Inc. increased its stake in shares of Monsanto Company (NYSE:MON) by 13.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,319 shares of the basic materials company’s stock after purchasing an additional 1,299 shares during the period. Pacer Advisors Inc.’s holdings in Monsanto were worth $1,356,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in MON. Level Four Advisory Services LLC grew its stake in shares of Monsanto by 10.5% during the first quarter. Level Four Advisory Services LLC now owns 9,382 shares of the basic materials company’s stock worth $1,082,000 after purchasing an additional 889 shares during the period. Paulson & CO. Inc. acquired a new position in Monsanto in the first quarter valued at about $4,019,000. Highbridge Capital Management LLC acquired a new position in Monsanto in the first quarter valued at about $20,376,000. Soros Fund Management LLC acquired a new position in Monsanto in the first quarter valued at about $4,907,000. Finally, Gotham Asset Management LLC grew its stake in Monsanto by 98.4% in the first quarter. Gotham Asset Management LLC now owns 164,239 shares of the basic materials company’s stock valued at $18,592,000 after acquiring an additional 81,463 shares during the period. 74.98% of the stock is owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2017/11/22/pacer-advisors-inc-has-1-36-million-position-in-monsanto-company-mon.html.
In other Monsanto news, VP Duraiswami Narain sold 2,860 shares of the company’s stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.00, for a total value of $343,200.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Brett D. Begemann sold 22,640 shares of the stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.03, for a total value of $2,717,479.20. Following the transaction, the chief operating officer now owns 85,439 shares in the company, valued at approximately $10,255,243.17. The disclosure for this sale can be found here. Insiders sold 49,236 shares of company stock worth $5,931,934 in the last 90 days. Corporate insiders own 0.79% of the company’s stock.
MON has been the subject of a number of research analyst reports. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $131.00 target price for the company in a research note on Monday, September 4th. BMO Capital Markets reissued a “buy” rating and issued a $128.00 target price on shares of Monsanto in a research note on Friday, September 1st. Jefferies Group LLC reissued a “hold” rating and issued a $128.00 target price on shares of Monsanto in a research note on Friday, September 15th. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Finally, Macquarie cut Monsanto from an “outperform” rating to a “neutral” rating in a research report on Wednesday, October 4th. Eleven investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $124.61.
Monsanto Company (MON) traded up $0.39 during trading hours on Wednesday, reaching $118.48. The company’s stock had a trading volume of 3,263,400 shares, compared to its average volume of 1,942,022. The company has a quick ratio of 0.83, a current ratio of 1.35 and a debt-to-equity ratio of 1.12. The company has a market capitalization of $51,983.22, a price-to-earnings ratio of 21.35, a price-to-earnings-growth ratio of 1.70 and a beta of 1.05. Monsanto Company has a 12-month low of $100.87 and a 12-month high of $122.79.
Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.61. The firm had revenue of $2.69 billion for the quarter, compared to analyst estimates of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.07 earnings per share. equities research analysts forecast that Monsanto Company will post 5.74 earnings per share for the current fiscal year.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.